The rise in number of counterfeit drugs is an oft-dicussed issue. It threatens not only patient safety, but the very future of research into pharmaceuticals. But there are few hard facts and a lot of speculation.

Professor Taylor, one of the world's leading experts, will discuss the facts, putting the scale of the problem into context. He will also look at what can be done to deal with one of the most dangerous developments in modern medicine.

Related CNE publications and events:

Feb 2006

A False Sense of Security: The Growing Threat of Counterfeit Pharmaceutical Products

 

David Taylor is Professor of Pharmaceutical and Public Health Policy at the School of Pharmacy, London University. He previously held positions in the Association of the British Pharmaceutical Industry, the King’s Fund and the Audit Commission, and served as Chairman of a Family Health Services Authority in the early 1990s.

Professor Taylor is currently a trustee of the Patients Association, and a member of the Department of Health’s Medicines Management Advisory Group. Professor Taylor’s main research interests are in health and health care improvement, and the pharmaceutical industry in society. He has completed a survey of primary care development in London, and worked on the introduction of the strategy contained in Pharmacy in the Future - Implementing the NHS Plan. He has been integral in developing a pharmaceutical and public health policy programme which is supporting pharmacists in extending their professional roles, and achieving improvements in both individual and community health. Professor Taylor’s research interests also include the impact of economic and quality management theory on health care policy and delivery, the changing nature of professionalism in the health sector, and issues relating to science policy and the ethical responsibilities of pharmaceutical companies in relation to national and global health problems.